Use of inhaled fluticasone propionate to control respiratory manifestations of relapsing polychondritis

8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Effective management of respiratory tract involvement is very important in improving the prognosis of relapsing polychondritis (RPC). This case report describes a 19-year-old patient with RPC, who required frequent hospitalization due to recurrent exacerbations of airway obstruction. Use of high-dose fluticasone propionate effectively reduced the amount of oral corticosteroid necessary to control inflammation of the airway mucosa and dramatically decreased the patient's obstructive airway impairment. This report is the first illustrating the effectiveness and safety of inhaled corticosteroids in the control of the respiratory manifestations of RPC. © 2008 Asian Pacific Society of Respirology.

Cite

CITATION STYLE

APA

Tsuburai, T., Suzuki, M., Tsurikisawa, N., Ono, E., Oshikata, C., Taniguchi, M., & Akiyama, K. (2009). Use of inhaled fluticasone propionate to control respiratory manifestations of relapsing polychondritis. Respirology, 14(2), 299–301. https://doi.org/10.1111/j.1440-1843.2008.01455.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free